Can artificial intelligence think like a cancer tumor board?

NCT ID NCT07746830

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This study asks whether an artificial intelligence system can make the same care recommendations as a team of cancer experts for people with stomach, colon, or rectal cancer. About 69 participants will have their medical information reviewed independently by both the AI and a multidisciplinary tumor board. An independent panel will then compare the two sets of recommendations to see how often they agree and whether the AI's suggestions are clinically sound. The AI's output is for research only and will not influence actual patient treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Multimodal artificial intelligence system for clinical decision support
What this could lead to
If AI aligns closely with expert tumor board decisions, it could support doctors in making faster, more consistent care plans for gastrointestinal cancers.
What could go wrong
This is a small, early observational study, so AI may not match expert judgment in all cases. AI recommendations are for research only and not used in patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLON CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ruijin hospital Shanghai Jiaotong University, School of Medicine

    Shanghai, Shanghai Municipality, 200025, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.